The Fibromyalgia Treatment Market Is Expected To Grow By $1,414.4 million during 2021-2027
Fibromyalgia, also known as fibromyalgia syndrome, is a common and complex chronic pain disorder that causes musculoskeletal discomfort, tiredness, and localized soreness and has an emotional, physical, and social impact. Hereditary problems are the most common cause; however, the actual cause is unknown. The most common fibromyalgia symptoms are chronic muscle pain, tiredness, sleeping problems, and painful areas. In addition, patients with fibromyalgia may also feel depressed, have headaches, and have difficulties concentrating. The global fibromyalgia treatment market is estimated to reach USD 1,414.4 million by 2027, growing at a 9.2 percent CAGR over that time. Over the forecast period, the global market is predicted to rise at a rapid rate. The rise of the global Fibromyalgia Treatment Market is being fueled by rising instances of acute stress and road accidents. In addition, increased population awareness, rising occurrences of rheumatic diseases, unmet medical needs in fibromy